AKT1 and major depressive disorder: In a recent study, it was discovered that the ethyl acetate fraction of Xiaoyaosan can treat depression by regulating the PI3K/Akt signaling pathway, reducing neuronal apoptosis, and fosters neurogenesis, thereby effectively treating depression (Zeng et al., 2022).